BloodSTOP® iX Helped Win Best in Category for Burn Wounds at the ABA’s 51st Annual Meeting

Last updated Jul 15, 2020 | News Category

BloodSTOP® iX created quite a buzz at the American Burn Association (ABA) 51st Annual Meeting on April 2-5, 2019! LifeScience PLUS (LSP) attended to showcase our BloodSTOP iX hemostasis dressing in two burn wound categories. To our great delight, one of the procedures won a coveted Blue Ribbon for Best in Category when used for hemostasis and wound healing.

These procedures were developed through our continued support to John H. Stroger, Jr. Hospital of Cook County Health and Rush University Medical Center, both in Chicago, IL. Two clinical abstracts were submitted in two Wounds categories:

  • A Novel Hemostatic Agent Improves Split-Thickness Skin Graft Donor Site Healing—T. Xu, MD; K. Kramer, MD; E. Koeck, MD; F. Bokhari, MD; S. Poulakidas, MD, was submitted in the Clinical IV category and won Best in Category for exceptional results in the control of bleeding and promotion of tissue healing.
  • Minimizing Intraoperative Hemorrhage in Wound Debridement Using a Novel Topical Hemostatic Agent—T. Xu, MD; K. Kramer, MD; E. Koeck, MD; F. Bokhari, MD; S. Poulakidas, MD, was submitted in the Clinical II category (full view with pictures).

    • The abstracts contained early case studies that demonstrated the ability of BloodSTOP iX to rapidly stop postdebridement bleeding and accelerate donor site healing.

    Surgeons Stathis Poulakidas, MD, OSF Medical Group and Cook County Health (left); Thomas Xu, MD, Rush University Medical Center (middle); with Lason Magallones, LSP (right).

    The abstracts contained early case studies that demonstrated the ability of BloodSTOP iX to rapidly stop postdebridement bleeding and accelerate donor site healing.

    Surgeons Stathis Poulakidas, MD, OSF Medical Group and Cook County Health (left); Thomas Xu, MD, Rush University Medical Center (middle); with Lason Magallones, LSP (right).